TABLE 2.
Reported tests available for HHCD patient clinical care and test locations closest to the patient care room in 32 U.S. HLIUs
| Test | No. (%) available |
|||||
|---|---|---|---|---|---|---|
| For HLIU | Within patient care room | Within isolation unit | Within facility | Outside facilitya | Other | |
| Complete blood count with automated differential | 29b (91) | 0 (0) | 16 (55) | 11 (38) | 0 (0) | 0 (0) |
| Basic metabolic panel | 29 (91) | 4 (13) | 17 (59) | 8 (28) | 0 (0) | 0 (0) |
| Magnesium level | 21 (66) | 0 (0) | 14 (67) | 7 (33) | 0 (0) | 0 (0) |
| Comprehensive metabolic panel | 25 (78) | 0 (0) | 15 (60) | 10 (40) | 0 (0) | 0 (0) |
| Ionized calcium level | 24 (75) | 4 (17) | 12 (50) | 7 (29) | 0 (0) | 1c (4) |
| Standard calcium level | 25 (78) | 0 (0) | 16 (64) | 9 (36) | 0 (0) | 0 (0) |
| Phosphorous level | 21b (66) | 0 (0) | 10 (48) | 9 (43) | 0 (0) | 0 (0) |
| Cortisol level | 8 (25) | 0 (0) | 0 (0) | 7 (88) | 0 | 1c (12) |
| Troponin level | 12 (38) | 0 (0) | 3 (25) | 8 (67) | 0 (0) | 1d (8) |
| Blood gas concentrations | 28 (88) | 4 (14) | 14 (50) | 10 (36) | 0 (0) | 0 (0) |
| Lactate level | 23 (72) | 3 (13) | 12 (52) | 8 (35) | 0 (0) | 0 (0) |
| Prothrombin time | 25 (78) | 3 (12) | 13 (52) | 9 (36) | 0 (0) | 0 (0) |
| Partial thromboplastin time | 16 (50) | 0 (0) | 8 (50) | 8 (50) | 0 (0) | 0 (0) |
| Platelet count | 28 (88) | 0 (0) | 15 (54) | 13 (46) | 0 (0) | 0 (0) |
| Blood typing | 16 (50) | 0 (0) | 6 (38) | 9 (56) | 0 (0) | 1e (6) |
| Blood culturef | 28 (88) | 0 (0) | 9 (32) | 17 (61) | 1 (4) | 1c (4) |
| Urine culturef | 14 (44) | 0 (0) | 2 (14) | 10 (71) | 1 (7) | 1c (7) |
| Other body fluid culturef | 15 (47) | 0 (0) | 3 (20) | 10 (67) | 1 (7) | 1c (7) |
| Molecular assay | 17b (53) | 0 (0) | 2 (12) | 8 (47) | 4 (24) | 1c (6) |
| Manual differentialg | 15 (47) | 0 (0) | 3 (20) | 12 (80) | 0 (0) | 0 (0) |
| Lipase level | 13 (41) | 0 (0) | 3 (23) | 10 (77) | 0 (0) | 0 (0) |
| Amylase level | 16h (50) | 0 (0) | 6 (38) | 9 (56) | 0 (0) | 0 (0) |
| Total creatine kinase level | 11 (34) | 0 (0) | 4 (36) | 7 (64) | 0 (0) | 0 (0) |
| Malaria smearg | 28h (88) | 0 (0) | 9 (32) | 18 (64) | 0 (0) | 0 (0) |
| HIV screen | 17 (53) | 0 (0) | 6 (35) | 10 (59) | 1 (6) | 0 (0) |
| Urinalysis | 24 (75) | 4 (17) | 12 (50) | 8 (33) | 0 (0) | 0 (0) |
| Pregnancy test | 23 (72) | 3 (13) | 11 (48) | 9 (39) | 0 (0) | 0 (0) |
| Cerebrospinal fluid analysisi | 7 (22) | 0 (0) | 0 (0) | 7 (100) | 0 (0) | 0 (0) |
a
For example, a PHL or reference laboratory.
b
Two HLIUs did not report where the test was located.
c
The health system's core laboratory.
d
Not planned but could be obtained from the i-Stat system if needed.
e
Not planned, but slide interpretation was available.
f
Microbiological assays, including inoculation of culture medium followed by incubation and pathogen identification if necessary.
g
Including staining and microscopic identification.
h
One HLIU did not report where the test was located.
i
Including microbiological analysis (culture and Gram staining), cell counting, and protein/glucose analysis.